Lung Cancer Clinical Trials

Lung Cancer Clinical Trials

Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy Sponsor and CollaboratorsUniversity of Miami Sylvester Comprehensive Cancer Center Principal InvestigatorEdgardo Santos, MD, University of Miami Sylvester Comprehensive Cancer Center ClinicalTrials.gov IdentifierNCT01209520Continue Reading

Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy Sponsor and CollaboratorsUniversity of Miami Sylvester Comprehensive Cancer Center Principal InvestigatorEdgardo Santos, MD, University of Miami Sylvester Comprehensive Cancer Center ClinicalTrials.gov IdentifierNCT01209520Continue Reading

Next post in Lung Cancer Clinical Trials